Clinical Studies & Resources
Salonpas® allocates significant resources to clinical study and product innovation that keeps us aligned to the needs of pain sufferers and the professional guidance that recommends a “topicals first” approach to pain management.
Clinical Studies of Salonpas® Products
![](https://salonpaspro.com/img/CS-Higashi-Study-250x250.jpg)
Higashi Study
From a randomized, double-blind, parallel-group, placebo-controlled, multicenter study forming the basis of our New Drug Application approval.
![](https://salonpaspro.com/img/CS-Relief-Study-60ct-250x250.jpg)
RELIEF Study
Observational study of benefits of Salonpas® Pain Relieving Patch on pain intensity, use of concurrent oral medications and BPI scores.
![Box of Salonpas Pain Relieving Patches with Maxtrix-like backdrop](https://salonpaspro.com/img/AI-Study-Image-250x250.jpg)
AI Study
Applying artificial intelligence (AI) to patient profile reveals which ones could benefit most from Salonpas®.
Treatment Guidelines
![missing image](https://salonpaspro.com/img/CS-CDC-250x250.jpg)
CDC
In response to the opioid crisis, the CDC released importance guidance for the use of topical analgesics as first line medicine.
![](https://salonpaspro.com/img/CS-ACP-AAFP-250x250.jpg)
ACP & AAFP
These two academies released guidance that recommends a “topical NSAIDs first approach” for acute non-low back musculoskeletal pain.
Additional Information on Topical Analgesics
![Dr. Gudin](https://salonpaspro.com/img/CS-Guide-QA-250x250.jpg)
Dr. Gudin Q&A
Esteemed doctor and Salonpas® Advisor shares his insights.
![Salonpas Pain Relief Patch products](https://salonpaspro.com/img/No1-Doc-Recommended-Image-250x250.jpg)
#1 Doctor Recommended
If you’re recommending Salonpas® to your patients, you’re in good company.